Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. SV Labs Prescott Corporation
WARNING LETTER
•SV Labs Prescott Corporation•June 13, 2025

SV Labs Prescott Corporation – FDA Warning Letter, Jun 13, 2025

Record Details

The FDA issued a Warning Letter to SV Labs Corporation following an inspection of its Prescott, Wisconsin, drug manufacturing facility from June 10 to 13, 2025. The letter details significant violations of Current Good Manufacturing Practice (CGMP) regulations for finished pharmaceuticals, rendering the company’s drug products adulterated under federal law.

Key violations include the firm’s failure to thoroughly investigate out-of-specification (OOS) results. For instance, an over-the-counter (OTC) SPF 30 sunscreen lotion lot with "too numerous to count" microbial contamination was released without adequate investigation, a repeat observation from a previous inspection. Additionally, an animal drug product was found contaminated with *Burkholderia cepacia complex* (BCC), but the investigation was insufficient, failing to assess other impacted batches or the water system as a source, despite a history of water system failures.

Furthermore, the facility failed to use appropriately designed equipment, specifically its legacy purified water system. This system contained dead legs, creating stagnant areas that fostered microbial contamination, which was confirmed by recurring water and drug product microbial failures.

The FDA deems the company’s responses inadequate and requires several actions. These include a retrospective, independent review of all drug products currently on the U.S. market within expiry to identify and address any substandard quality. SV Labs must also provide an action plan for BCC testing of retain samples, and a comprehensive remediation plan for their OOS investigation systems. Finally, a detailed remediation plan for the water system"s design, construction, and validation, demonstrating its suitability for pharmaceutical use, is mandated.

Company
SV Labs Prescott Corporation
Inspection date
June 13, 2025
Product type
Otc (Over-The-Counter)
Office
Center for Drug Evaluation and Research
People
  • Graham Orriss
  • Jill P. Furman (Director)
  • Dillard H. Woody Jr. (Acting Director)
View Company Profile

ID · dd878dd8-b4c8-4144-8624-22a327d773d3

Violation Codes10
21 U.S.C. 351(a)(2)(B)21 CFR 211.2221 CFR 211.194(a)21 CFR 21021 CFR 211.19221 CFR 211.68(b)21 CFR 211.3421 CFR 21121 CFR 211.6321 CFR 211.160(b)

Full citation text and observation details available on the Dashboard.

Other documents for SV Labs Prescott Corporation
  • 483 - 2025-06-13June 13, 2025
  • 483 - 2018-09-28September 28, 2018

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore SV Labs Prescott Corporation
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.